The American Dental Association (ADA) has expressed its support of House Bill Small Business PPE Tax Credit Act (HR 7216), which provides a tax credit for small businesses to offset the expense of purchasing personal protective equipment…

A Phase 3 clinical trial on a COVID-19 vaccine being developed by AstraZeneca in partnership with Oxford University was put on hold after a participant in the United Kingdom (UK)-based study developed severe spinal cord inflammation. The…

Patients are returning to the dental office, with 99% of practices open and patient volumes hovering at nearly 75% of pre-pandemic rates, according to the American Dental Association Health Policy Institute. This healthy recovery may be…

Research shows that those who experience the most severe COVID-19 symptoms are often obese. A recent meta-analysis of nearly 400,000 patients published in Obesity Reviews found that people with obesity and COVID-19 were 113% more likely to…

Pittsburgh’s Carnegie Mellon University (CMU) has received a $1 million donation, as well as a team of Google fellows—including software engineers and researchers—at no cost to CMU, to support its COVID-19 forecasting project. The project,…

The United States Food and Drug Administration (FDA) issued a warning letter on September 10 to Pharmacy Plus Inc for fraudulently claiming its products are helpful against COVID-19. The company makes “COVID PACK” and “COVID ‘POSITIVE’…

The Paycheck Protection Small Business Forgiveness Act (S 4117) has been introduced in the Senate by a bipartisan group of senators from across the United States, and is strongly supported by the American Dental Association (ADA). The bill…

A significant adverse reaction was noted in one participant of a clinical trial on a COVID-19 vaccine being developed by AstraZeneca in partnership with Oxford University.

Kathleen T. O’Loughlin, DMD, MPH, executive director of the American Dental Association, asked members of a National Academies, Engineering, and Medicine panel—who are working on a plan for the equitable distribution of COVID-19 vaccines—to…

While the United States has spent more than $10 billion on vaccine development, funds have not been allocated to support public health departments in rolling out two COVID-19 vaccines that may be ready as early as late October or the…